# Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin

Source: https://onco.cc/trials/nct07188441/  
OnCo record `nct07188441` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Teniposide and Cisplatin in Germ cell tumours of childhood and adolescence, run by Chengcheng Guo, now recruiting.

## Summary

Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin is a phase 2 interventional study registered as NCT07188441 by Chengcheng Guo, with 40 participants planned, started 2024-08-13 and due to reach its primary completion in 2026-12. Interventions recorded: Teniposide Injection. Conditions recorded: GCT, Germ Cell Tumor, Central Malignant Germ Cell Tumor.

Linked to the drug Teniposide because the registry names it among its interventions and Germ cell tumours of childhood and adolescence among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07188441
- Phase: 2
- Setting: A Single-center, Single-arm, Open-label Study of the Combination of Teniposide Injection and Cisplatin in the Treatment of Newly Diagnosed Patients With Central Malignant Germ Cell Tumors.
- Sponsor: Chengcheng Guo
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT07188441: https://clinicaltrials.gov/study/NCT07188441

## Connected records

- cancers: [Germ cell tumours of childhood and adolescence (extracranial and CNS)](https://onco.cc/cancers/paediatric-germ-cell-tumours/)
- drugs: [Cisplatin](https://onco.cc/drugs/cisplatin/), [Teniposide](https://onco.cc/drugs/teniposide/)

---
JSON: https://onco.cc/api/v1/entities/nct07188441.json